Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NMRA
NMRA logo

NMRA News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NMRA News

Biotech Sector Sees FDA Approvals and Layoffs

Jun 19 2026NASDAQ.COM

Neumora Therapeutics Faces Stock Collapse After Failed Trials

Jun 17 2026PRnewswire

Neumora Therapeutics Shares Plunge Nearly 50% After Trial Failures

Jun 16 2026Newsfilter

Neumora Therapeutics Shares Plunge Nearly 50% After Trial Failures

Jun 16 2026PRnewswire

Neumora Therapeutics Cuts 35% Workforce to Conserve Cash

Jun 15 2026stocktwits

Neumora Discontinues Navacaprant Development for Depression

Jun 15 2026Globenewswire

Neumora Therapeutics Shares Plunge 50% After Phase 3 Trial Failure

Jun 15 2026seekingalpha

Neumora Therapeutics to Participate in Healthcare Conference

Apr 06 2026Newsfilter

NMRA Events

No data

No data

NMRA Monitor News

No data

No data

NMRA Earnings Analysis

No Data

No Data

People Also Watch